Cytomx Therapeutics Inc (CTMX)

03:11 AM

Published on: 2025-12-04 14:11:00 - Newser

03:11 AM

02:27 AM

Is CytomX Therapeutics Inc. (6C1) stock attractive post correction2025 Investor Takeaways & Daily Price Action Insights - Newser

02:27 AM

01:58 AM

Will CytomX Therapeutics Inc. (6C1) stock sustain dividend payoutsJuly 2025 Sector Moves & Verified Short-Term Plans - Newser

01:58 AM

01:34 AM

Will CytomX Therapeutics Inc. stock beat EPS estimatesForecast Cut & Capital Efficient Trade Techniques - Newser

01:34 AM

Dec 03, 2025

Why CytomX Therapeutics Inc. (6C1) stock is listed among top recommendationsMarket Activity Summary & Capital Protection Trade Alerts - Newser

Dec 03, 2025

Dec 03, 2025

Is CytomX Therapeutics Inc. (6C1) stock ideal for retirement investorsJuly 2025 Patterns & Fast Gain Stock Trading Tips - Newser

Dec 03, 2025

Dec 03, 2025

What insider purchases suggest about CytomX Therapeutics Inc. (6C1) stockFed Meeting & Fast Gain Stock Trading Tips - Newser

Dec 03, 2025

Dec 03, 2025

Is CytomX Therapeutics Inc. (6C1) stock a buy on weaknessQuarterly Trade Summary & Fast Entry High Yield Tips - Newser

Dec 03, 2025

Dec 03, 2025

Will CytomX Therapeutics Inc. (6C1) stock outperform Dow JonesSell Signal & High Return Stock Watch Alerts - Newser

Dec 03, 2025

Dec 03, 2025

How CytomX Therapeutics Inc. (6C1) stock reacts to weak economy2025 Price Targets & Entry Point Confirmation Alerts - Newser

Dec 03, 2025

Dec 02, 2025

Portfolio Shifts: Is CytomX Therapeutics Inc 6C1 stock undervalued by metricsWeekly Loss Report & Daily Technical Stock Forecast Reports - BỘ NỘI VỤ

Dec 02, 2025

Dec 02, 2025

Is CytomX Therapeutics Inc. stock a contrarian buyWeekly Trend Report & Daily Technical Forecast Reports - Newser

Dec 02, 2025

Dec 02, 2025

Will CytomX Therapeutics Inc. (6C1) stock benefit from infrastructure billWeekly Volume Report & High Conviction Buy Zone Picks - Newser

Dec 02, 2025

Dec 02, 2025

Is CytomX Therapeutics Inc. (6C1) stock suitable for passive index fundsTrade Volume Summary & Risk Controlled Stock Pick Alerts - Newser

Dec 02, 2025

Dec 02, 2025

Why CytomX Therapeutics Inc. (6C1) stock is a strong buy callQuarterly Profit Report & Daily Market Momentum Tracking - Newser

Dec 02, 2025

Dec 02, 2025

What analyst consensus says on CytomX Therapeutics Inc. stockMarket Performance Summary & Risk Managed Trade Strategies - Newser

Dec 02, 2025

Nov 30, 2025

CapEx per share of CytomX Therapeutics, Inc. – DUS:6C1 - TradingView

Nov 30, 2025

Nov 30, 2025

Revenue per share of CytomX Therapeutics, Inc. – DUS:6C1 - TradingView

Nov 30, 2025

Nov 30, 2025

Is CytomX Therapeutics Inc. stock a top pick in earnings seasonJuly 2025 Decliners & Real-Time Volume Analysis Alerts - BỘ NỘI VỤ

Nov 30, 2025

Nov 29, 2025

CytomX Therapeutics jumps 54% after Q1 beat, prices $100M offering - MSN

Nov 29, 2025

Nov 29, 2025

CTMX (CytomX Therapeutics) Other Income (Minority Interest) : $0.0 Mil (TTM As of Sep. 2025) - GuruFocus

Nov 29, 2025

Nov 29, 2025

CX-2051 Momentum and An Expanding Oncology Pipeline Strengthen CytomX Therapeutics’ (CTMX) Investment Case - Insider Monkey

Nov 29, 2025

Nov 28, 2025

Will CytomX Therapeutics Inc. stock recover faster than peers2025 Historical Comparison & Fast Entry High Yield Tips - BỘ NỘI VỤ

Nov 28, 2025

Nov 28, 2025

Is CytomX Therapeutics Inc. (6C1) stock attractive for dividend growthJuly 2025 Snapshot & Technical Pattern Based Buy Signals - moha.gov.vn

Nov 28, 2025

Nov 27, 2025

Can CytomX Therapeutics Inc. stock sustain free cash flow growth2025 Price Targets & Weekly Watchlist for Hot Stocks - BỘ NỘI VỤ

Nov 27, 2025

Nov 26, 2025

Will CytomX Therapeutics Inc. stock split attract more investors2025 Key Lessons & Long-Term Growth Portfolio Plans - BỘ NỘI VỤ

Nov 26, 2025

Nov 26, 2025

ON Partners Recruits Chief Business Officer for CytomX Therapeutics - Hunt Scanlon Media

Nov 26, 2025

Nov 25, 2025

CytomX Therapeutics to Present at Upcoming December Investor Conferences - The Manila Times

Nov 25, 2025

Nov 22, 2025

Why Analysts Say the CytomX Story Is Evolving After Recent Clinical Momentum and Price Target Hike - Yahoo Finance

Nov 22, 2025

Nov 22, 2025

CytomX Therapeutics (CTMX) Price Target Increased by 15.12% to 7.21 - MSN

Nov 22, 2025

Nov 21, 2025

CytomX Therapeutics Inc Stock Analysis and ForecastVolume Profile Analysis & Superior Portfolio Investment - earlytimes.in

Nov 21, 2025

Nov 21, 2025

Will CytomX Therapeutics Inc. stock deliver consistent dividendsTrade Entry Report & Expert Curated Trade Setup Alerts - newser.com

Nov 21, 2025

Nov 21, 2025

Will CytomX Therapeutics Inc. stock see insider buyingEarnings Overview Summary & Low Risk High Reward Ideas - newser.com

Nov 21, 2025

Nov 21, 2025

Why CytomX Therapeutics Inc. (6C1) stock gets analyst attentionExit Point & High Accuracy Buy Signal Tips - newser.com

Nov 21, 2025

Nov 21, 2025

CTMX (CytomX Therapeutics) Price-to-Operating-Cash-Flow : (As of Nov. 20, 2025) - GuruFocus

Nov 21, 2025

Nov 20, 2025

CytomX at Jefferies Conference: Promising Cancer Treatment Insights By Investing.com - Investing.com Canada

Nov 20, 2025

Nov 20, 2025

CytomX Therapeutics stock holds Overweight rating at Cantor Fitzgerald By Investing.com - Investing.com Canada

Nov 20, 2025

Nov 19, 2025

Is CytomX Therapeutics Inc. stock a bargain at current levelsWeekly Risk Report & Consistent Income Trade Recommendations - newser.com

Nov 19, 2025

Nov 19, 2025

What technical charts say about CytomX Therapeutics Inc. stockJuly 2025 Fed Impact & Free Verified High Yield Trade Plans - newser.com

Nov 19, 2025

Nov 19, 2025

How CytomX Therapeutics Inc. (6C1) stock behaves in tightening cyclesRecession Risk & Low Drawdown Investment Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

CTMX (CytomX Therapeutics) Dividend Payout Ratio : 0.00 (As of Sep. 2025) - GuruFocus

Nov 19, 2025

Nov 19, 2025

CTMX (CytomX Therapeutics) Short-Term Debt : $0.0 Mil (As of Sep. 2025) - GuruFocus

Nov 19, 2025

Nov 19, 2025

CTMX (CytomX Therapeutics) Accounts Payable & Accrued Expen - GuruFocus

Nov 19, 2025